Spain 3D Imaging Market Analysis Report 2022 to 2030

Spain 3D Imaging Market Analysis

$ 3999

Spain's 3D Imaging market is projected to grow from $0.59 Bn in 2022 to $1.86 Bn by 2030, registering a CAGR of 15.5% during the forecast period of 2022-30. The market will be driven by the increase in outpatient diagnostic services and the rise in minimally invasive surgical techniques. The market is segmented by product, by application, end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers & Philips Healthcare.

ID: IN10ESDH001 CATEGORY: Digital Health GEOGRAPHY: Spain AUTHOR: Vidhi Upadhyay

Buy Now

Spain 3D Imaging Market Executive Summary

Spain's 3D imaging market is projected to grow from $0.59 Bn in 2022 to $1.86 Bn by 2030, registering a CAGR of 15.5% during the forecast period of 2022-30. According to the World Health Organization Global Health Expenditure database, the current health expenditure (%GDP) of Spain was found rise from 8.99% in 2018 to 9.13% in 2019 with total health spending of $3,616 per capita which includes personal healthcare and collective health services excluding spending on investments. Hospital services accounted for the greatest share in the spending by sector with pharmacies and primary care leading next. Cancer is one of the leading causes of death and disease in Spain, with an expected 276,239 new cases of cancer in 2021. Cardiovascular disease is also one of the top causes of mortality in Spain, accounting for 32% of all fatalities.

Cancer, heart disease, bone fractures, and brain and spinal cord problems are among the ailments for which 3D imaging is used to diagnose and monitor. 3D imaging is important in the Spanish healthcare business, having several applications in various medical disciplines such as Radiology, cardiology, orthopedics, neurology, and cancer are among the uses.

spain 3D imaging market analysis

Market Dynamics

Market Growth Drivers

The industry is expected to grow in the coming years due to an increase in outpatient surgery. The rise in minimally invasive surgical techniques will be a significant driver of the market over the projected period. Research and innovation, investments, and technological advancements in diagnostic imaging equipment are expected to generate profitable prospects for market participants. Furthermore, the use of 3D imaging in treatment planning and monitoring, such as angioplasty, joint replacement surgery, and radiation therapy, is adding to the country's expanding popularity.

Market Restraints

The high cost of technology, a dearth of experienced specialists, restricted reimbursement rules, competition from traditional imaging modalities, and privacy and security issues all pose hurdles to the 3D imaging business in Spain.

Competitive Landscape

Key Players

GE Healthcare
Siemens Healthineers
Philips Healthcare
Hitachi Healthcare
Toshiba Medical Systems
QMENTA (ESP)

Notable Deals

January 2023, GE HealthCare has agreed to acquire IMACTIS (Grenoble, France), a pioneer in the rapidly expanding field of CT interventional guiding across a wide range of treatment areas
In February 2023, Philips joined the European Federation for Cancer Images (EUCAIM) to enhance precision medicine for cancer patients in Europe
July 2022, Siemens Healthineers at the European Congress of Radiology (ECR) in Vienna, unveiled its most economical X-ray equipment to date. The system is intended to provide more access to care

Healthcare Policies and Regulatory Landscape

The Ministry of Health is in charge of managing the healthcare industry in Spain and ensuring that patients receive quality care. The Ministry of Health is responsible for establishing healthcare policy, financing healthcare services, and regulating the sale and usage of medical devices, including 3D imaging technology.

The Spanish Agency for Medicines and Health Products (AEMPS) assures that medical devices are safe, effective, and satisfy quality criteria. The Spanish Society of Radiology (SER) is a medical association that represents Spanish radiologists. The SER promotes the use of 3D imaging and advocates for radiologists and their patient’s needs.

Reimbursement Scenario

In Spain, reimbursement for 3D imaging is provided by the National Health System (NHS). The kind of treatment, the patient's health condition, and the patient's age all influence reimbursement for 3D imaging services. Some 3D imaging services may be fully covered by the NHS, while others may necessitate co-payments or other out-of-pocket charges.

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Spain 3D Imaging Market Segmentation

By Product (Revenue, USD Billion):

The 3D Imaging Market is divided majorly into X-ray Imaging Systems, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound & Nuclear Imaging Systems. X-ray Imaging systems have the highest market share in the 3D Imaging market. 3D X- rays are mostly utilized for dental and orthopedic applications. 3D Ultrasound is majorly helpful in tracking the dynamic motion of arteries, and veins and also has applications for various fetal, cardiac, obstetric, and rectal examinations, and many more. The ultrasound segment is predicted to develop substantially over the forecast period, primarily to the advancements in technology in the healthcare industry and the several advantages given by 3D ultrasound imaging over standard ultrasound imaging.

X-ray Imaging Systems
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Ultrasound
Nuclear Imaging systems

By Application (Revenue, USD Billion):

The market for 3D Imaging has applications covering Cardiology, Neurology, Orthopaedics, Gynaecology, Oncology, and other areas of diagnostics as well. Cardiovascular diseases are the leading cause of death globally. The second biggest cause is cancers because of which Oncology holds the highest market share in the 3D Imaging market followed by cardiology as 3D imaging is highly utilized in these two segments for diagnostics and treatments of the same. Neurosurgeons desire three-dimensional (3D) imagery of intracranial tumors, neural structures, skulls, and veins to establish a clear visual image of the surgical field's anatomical orientation prior to surgical intervention aiding better surgical outcomes for patients. Obstetricians employ 3D ultrasound scans to see the gestational sac, pinpoint the location of an ectopic pregnancy, and evaluate for fetal deformities of the face, spine, limbs, and heart. 3D Imaging applications for gynecology are yet in evolving stage and have a great scope for expansion allowing feasible and quick patient care.

Cardiology
Neurology
Orthopedics
Gynecology
Oncology
Others (Urology, etc.)

By End User (Revenue, USD Billion):

Hospitals, Diagnostic Imaging Centers, and other end-user such as private clinics make up the segments of the 3D Imaging Market. The hospitals among these hold the biggest market share due to the increased uptake of cutting-edge medical technology, the expansion of existing 3D Imaging facilities, the rising affordability of 3D Imaging services, the rising prevalence of chronic conditions such as cardiovascular diseases, cancers, respiratory diseases which lead to rising in demand for precise and quick diagnostic and treatment options. Diagnostic Imaging Centers have also been deploying 3D Imaging equipment to improve their standard of care.

Hospitals
Diagnostic Imaging Centers
Other End Users

By Portability (Revenue, USD Billion):

The 3D Imaging market is divided into two segments Stationary & Mobile, considering the portability of the device. Stationary 3D imaging involves equipment that is installed at a particular location and is operated from the same location of installment whereas mobile ones can be relatively smaller in size and hence moved to the patients who are unable to locate the Imaging room. Mobile MRI, Ultrasound, X–ray & CT allow cutting-edge healthcare to be delivered to nearly any location and are yet in the developing stages of expansion.

Stationary
Mobile

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.